ST-segment myocardial infarction
Conditions
Brief summary
Final infarct size (% of left ventricle mass) measured on late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) 3 months following index event.
Detailed description
The extent of microvascular obstruction (MVO) on cardiac magnetic resonance (CMR), The extent of hemorrhage on cardiac magnetic resonance (CMR), Other cardiac magnetic resonance (CMR) efficacy parameters as specified in appendix A, All-cause mortality and hospitalization for heart failure at 3 months, Peak Troponin-T and creatine kinase myocardial band (CKMB), Safety: Incidence of adverse events the first seven days of the index event
Interventions
Sponsors
Rigshospitalet, Rigshospitalet
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Final infarct size (% of left ventricle mass) measured on late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) 3 months following index event. | — |
Secondary
| Measure | Time frame |
|---|---|
| The extent of microvascular obstruction (MVO) on cardiac magnetic resonance (CMR), The extent of hemorrhage on cardiac magnetic resonance (CMR), Other cardiac magnetic resonance (CMR) efficacy parameters as specified in appendix A, All-cause mortality and hospitalization for heart failure at 3 months, Peak Troponin-T and creatine kinase myocardial band (CKMB), Safety: Incidence of adverse events the first seven days of the index event | — |
Countries
Denmark
Outcome results
None listed